SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-19-000192
Filing Date
2019-06-17
Accepted
2019-06-17 13:14:08
Documents
16
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. FORM 6K avricore6knov2018.htm 6-K 9731
2 NEWS RELEASE ex99-1.htm EX-99 6204
3 MATERIAL CHANGE REPORT ex99-2.htm EX-99 7036
4 NEWS RELEASE ex99-3.htm EX-99 16642
5 CERTIFICATE OF NAME CHANGE ex99-4.htm EX-99 538
6 FINANCIAL STATEMENTS ex99-5.htm EX-99 376466
7 MANAGEMENT'S DISCUSSION AND ANALYSIS ex99-6.htm EX-99 122256
8 CERTIFICATION ex99-7.htm EX-99 7917
9 CERTIFICATION ex99-8.htm EX-99 7800
10 ex9911.jpg GRAPHIC 22379
11 ex9931.jpg GRAPHIC 8441
12 ex9941.jpg GRAPHIC 92244
13 ex9951.jpg GRAPHIC 8441
14 ex9961.jpg GRAPHIC 10746
15 ex9962.jpg GRAPHIC 21405
16 ex9963.jpg GRAPHIC 39882
  Complete submission text file 0001052918-19-000192.txt   836936
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 19900995
SIC: 2834 Pharmaceutical Preparations